RBC Bioscience Corporation Stock Price

TPEX:6848 Community·NT$210.9m Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create a narrative

6848 Share Price Performance

NT$16.25

-1.57 (-8.80%)

NT$16.25

-1.57 (-8.80%)

NT$16.25

Thu, 19 Feb 26

Share Pricen/a

6848 Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Slight risk with acceptable track record.

4 Risks

1 Reward

View Full Analysis

RBC Bioscience Corporation Key Details

Last Reported Earnings

Jun 30, 2025

Next Reporting Earnings

n/a

: 1.51
: 48.03%
: 9.71%
: 167.1%

View Full Analysis

About 6848

Founded: 1995
Employees: 52
CEO: Mingwei Zhuo
WebsiteView website: www.rbcbioscience.com

RBC Bioscience Corporation manufactures and sells reagents and devices for life science and molecular diagnosis Taiwan. It offers MagCore Plus II Automated Nucleic Acid Extractor, a robotic bench-top workstation for nucleic acid purification; MagCore Super Automated Nucleic Acid Extractor, an automated workstation for nucleic acid extraction; and MagCore® EDA Automatic Extraction and Smart PCR Setup, an instrument for nucleic acid extraction and PCR setup pre-treatment. The company also provides NGS, genomic DNA, viral nucleic acids, and total RNA kits. RBC Bioscience Corporation was founded in 1995 and is based in New Taipei City, Taiwan.